Skinvisible (SKVI) Change in Accured Expenses (2010 - 2026)

Skinvisible has disclosed Change in Accured Expenses across 17 years of filings, most recently posting $101292.0 for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $101292.0, up 0.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $395637.0 (down 7.22% YoY), and the FY2025 annual result was $394676.0, down 6.1% from the prior year.
• Change in Accured Expenses came in at $101292.0 for Q1 2026 at Skinvisible, up from $97013.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $490421.0 in Q3 2024 to a low of -$291120.0 in Q4 2024.
• The 5-year median for Change in Accured Expenses is $99852.0 (2023), against an average of $94816.1.
• Across the five-year window, Change in Accured Expenses surged 1479.14% in 2022 and sank 363.82% in 2024, its largest moves.
• Skinvisible's Change in Accured Expenses stood at $91006.0 in 2022, then increased by 21.25% to $110349.0 in 2023, then tumbled by 363.82% to -$291120.0 in 2024, then surged by 133.32% to $97013.0 in 2025, then rose by 4.41% to $101292.0 in 2026.
• The last three Change in Accured Expenses figures came in at $101292.0 (Q1 2026), $97013.0 (Q4 2025), and $75504.0 (Q3 2025), per Business Quant data.